These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 578519)
1. Potential systemic side effects of six common ophthalmic drugs. Hopkins GA; Lyle WM J Am Optom Assoc; 1977 Oct; 48(10):1241-5. PubMed ID: 578519 [TBL] [Abstract][Full Text] [Related]
2. Systemic effects of eye drops. Davidson SI Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):487-95. PubMed ID: 4143267 [No Abstract] [Full Text] [Related]
3. Systemic toxicity of cyclopentolate hydrochloride in adults following topical ocular instillation. Awan KJ Ann Ophthalmol; 1976 Jul; 8(7):803-6. PubMed ID: 962257 [TBL] [Abstract][Full Text] [Related]
4. Adverse reactions to topical ocular autonomic agents. Norden LC J Am Optom Assoc; 1978 Jan; 49(1):75-80. PubMed ID: 146723 [No Abstract] [Full Text] [Related]
5. Acute psychosis associated with topical cyclopentolate hydrochloride. Khurana AK; Ahluwalia BK; Rajan C; Vohra AK Am J Ophthalmol; 1988 Jan; 105(1):91. PubMed ID: 3337198 [No Abstract] [Full Text] [Related]
6. Pharmacodynamic effects of pilocarpine eye drop enhanced by decreasing its volume of instillation. Lal A; Kataria V; Rajpal A; Khanna N Indian J Physiol Pharmacol; 1995 Jul; 39(3):267-70. PubMed ID: 8550123 [TBL] [Abstract][Full Text] [Related]
11. Effect of combined 1% cyclopentolate-10% phenylephrine eye drops on systemic blood pressure of glaucoma patients. Epstein DL; Murphy E Ann Ophthalmol; 1981 Jun; 13(6):735-6. PubMed ID: 7258971 [TBL] [Abstract][Full Text] [Related]
12. Myoclonic seizure due to cyclopentolate eye drop in a preterm infant. Büyükcam A; Celik HT; Korkmaz A; Yurdakök M Turk J Pediatr; 2012; 54(4):419-20. PubMed ID: 23692725 [TBL] [Abstract][Full Text] [Related]
13. Effects of antiglaucoma drugs on ocular hemodynamics in healthy volunteers. Schmetterer L; Strenn K; Findl O; Breiteneder H; Graselli U; Agneter E; Eichler HG; Wolzt M Clin Pharmacol Ther; 1997 May; 61(5):583-95. PubMed ID: 9164420 [TBL] [Abstract][Full Text] [Related]
14. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops. Korte JM; Kaila T; Saari KM Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic pharmaceutical agents: side effects encountered in a study of 15,000 applications. Yolton DP; Kandel JS; Yolton RL J Am Optom Assoc; 1980 Feb; 51(2):113-8. PubMed ID: 6768788 [TBL] [Abstract][Full Text] [Related]
16. Mydriatic and cycloplegic drugs: a review of ocular and systemic complications. Rengstorff RH; Doughty CB Am J Optom Physiol Opt; 1982 Feb; 59(2):162-77. PubMed ID: 7039329 [TBL] [Abstract][Full Text] [Related]
17. Psychotic reaction in an adult after topical cyclopentolate. Shihab ZM Ophthalmologica; 1980; 181(3-4):228-30. PubMed ID: 7231890 [TBL] [Abstract][Full Text] [Related]
18. [Systemic side effects of topical ophthalmic drugs]. Bodd E; Lunde PK Tidsskr Nor Laegeforen; 1990 Apr; 110(11):1375. PubMed ID: 2339383 [No Abstract] [Full Text] [Related]
20. Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma. Gelatt KN; Larocca RD; Gelatt JK; Strubbe DT; MacKay EO Am J Vet Res; 1995 Oct; 56(10):1325-31. PubMed ID: 8928950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]